The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols

Show simple item record

dc.contributor.advisor Bester, Megan J. en
dc.contributor.postgraduate Green, Pieter-Hendrik en
dc.date.accessioned 2013-09-07T12:53:06Z
dc.date.available 2005-09-23 en
dc.date.available 2013-09-07T12:53:06Z
dc.date.created 2003-09-10 en
dc.date.issued 2005-09-23 en
dc.date.submitted 2005-09-22 en
dc.description Dissertation (MSc (Chemical Pathology))--University of Pretoria, 2005. en
dc.description.abstract Please read the abstract in the section 00front of this document en
dc.description.availability unrestricted en
dc.description.department Chemical Pathology en
dc.identifier.citation Green P-H, 2003, The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols, MSc dissertation, University of Pretoria, Pretoria, viewed yymmdd < http://hdl.handle.net/2263/28108 > en
dc.identifier.other H1184/th en
dc.identifier.upetdurl http://upetd.up.ac.za/thesis/available/etd-09222005-111752/ en
dc.identifier.uri http://hdl.handle.net/2263/28108
dc.language.iso en
dc.publisher University of Pretoria en_ZA
dc.rights © 2003 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. en
dc.subject Genetic polymorphisms en
dc.subject Caucasian race south africa en
dc.subject Anticoagulants medicine en
dc.subject Warfarin en
dc.subject UCTD en_US
dc.title The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols en
dc.type Dissertation en


Files in this item

This item appears in the following Collection(s)

Show simple item record